Creative Medical Technology Holdings Inc (CELZ) Technical Analysis
$2.650%
Market is closed - opens 7 PM, 01 Jul 2025
Insights
- Creative Medical Technology is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Creative Medical Technology stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Creative Medical Technology stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Creative Medical Technology stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 63.18 | Sell |
Stochastic | 70.71, 79.26 | Neutral |
Ultimate Oscillator | 42.77 | Neutral |
Stochastic Relative Strength Index | 88.4, 92.16 | Sell |
Moving Average Convergence Divergence | 0.14, 0.09 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.47 | Buy |
20 | 2.38 | Buy |
50 | 2.15 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.53 | Buy |
20 | 2.41 | Buy |
50 | 2.37 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.52 | Buy |
20 | 2.41 | Buy |
50 | 2.25 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.69 | Buy |
20 | 2.58 | Buy |
50 | 2.19 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.74 | Buy |
20 | 2.7 | Buy |
50 | 2.37 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 3.17 |
Resistance L2 | 3.02 |
Resistance L1 | 2.9 |
Pivot Point | 2.75 |
Support L1 | 2.63 |
Support L2 | 2.48 |
Support L3 | 2.37 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.